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sponge. By then she had lost 7 L of blood, for which she received six
packed cells, four fresh frozen plasma and two thrombocytic units. In
the next days in the ICU, she was diagnosed with an occlusion and
dissection of the left internal iliac artery. Stent-assisted mechanical
thrombectomy was performed successfully. Six days after the delivery
she went home in relatively good condition with a haemoglobin level
of 5.7 mmol/L. She failed to attend our preconception care clinic prior
to the next pregnancy, and was referred in the second trimester of her
second pregnancy by another medical centre where she was under
antenatal care.1. Summary
In the following case report, a 32-year old G2P1 will be presented
with a complicated obstetric history of severe postpartumhaemorrhage
(7 L). Pro-active management by ﬁbrinogen supplementation during
labour, in addition to standard active management, will be discussed
as an effective means to reduce blood loss. In our case, intensive
collaboration with the anaesthesiologist during pregnancy and labour
signiﬁcantly reduced obstetric haemorrhage during her second delivery
and illustrates the importance of a multidisciplinary approach.
2. Case Presentation
2.1. Obstetric History
A 30 year old woman of Asian origin, primigravida, BMI 17 (1.63 m
and 44 kg at the start of antenatal care) was referred to our hospital
by her attending midwife because of long-term rupture of the
membranes at term.
Labour was induced by intravenous oxytocin and she received
epidural anaesthesia. Because of foetal distress, a ventouse delivery
was performed and a healthy daughter was born. Placenta and mem-
branes followed spontaneously within 5 min. The third stage was com-
plicated by severe haemorrhage following delivery of the placenta.
Oxytocin was administered intravenously and 800 μg of misoprostol
was given rectally. The bleeding persisted and she was admitted into
surgery. She received sulproston, cyklokapron and vitamin K. Because
of persisting uterine atony the uterine arteries were embolized by the31 78 6541897.
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In her second pregnancy our patient was assessed at the anaesthetic
outpatient clinic.
At a gestational age of 33weeks and 2 days her haemoglobin levelwas
6.9mmol/L, platelets 125 10e 9/L and ﬁbrinogen 3.7 g/L. At 35weeks and
5 days vonWillebrand factor was 191 and factor VIII 144% (normal levels
in pregnancy). At 37 weeks and 1 day her ﬁbrinogen level showed a
decreased level of 3.2 g/L. This was interpreted as abnormal, presuming
that ﬁbrinogen levels increase during pregnancy. The medical staff
decided that shewould deliver in the operating room and that ﬁbrinogen
levels would have been measured during delivery.4. Second Delivery
At term, a planned induction was initiated by artiﬁcial rupture of
membranes and oxytocin at a gestational age of 38 weeks and 1 day.
Pre-labour her haemoglobin level was 7.0 mmol/L, platelets 93 10e 9/L
and ﬁbrinogen 2.9 g/L, again showed a decrease. She was taken to the
operating room at 8 centimetre dilation. Second stagewas uncomplicat-
ed and in 15min she delivered a healthy girl. Immediately after delivery
she received oxytocin and a urinary catheter was inserted. In the OR
ﬁbrinogen level was measured again and was decreased to 2.3 g/L. Her
uterus was again hypotonic and she lost 600 mL of blood when the
placenta was delivered. 800 μg of misoprostol was given rectally, oxyto-
cin was replaced by sulproston, 2 mg of methylergometrine, 2 g of
ﬁbrinogen was administered and 1 g of tranexamic acid. Thereafter,
the bleeding stopped and no further interventions were necessary.
During delivery and postpartum her prothrombin levels weremeasured
and stayed at 10 s. Total blood loss was 2.0 L. Postpartum her
haemoglobin level was 6.3 mmol/L, platelets 71 10e 9/L and ﬁbrinogen
3.0 g/L, calcium 1.17 mmol/L.C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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One day after the second delivery she was discharged with her
daughter in good condition. Six weeks later the mother and her daugh-
terwere doingwell and shewas satisﬁed about themanagement during
this second delivery.
6. Investigations
The questions arise as to why this woman had such extended
haemorrhage during delivery and how to prevent this from happening
again in a second delivery.
Charbit et al. published evidence of low ﬁbrinogen levels in women
with severe postpartum haemorrhage (PPH). He suggested that simple
ﬁbrinogen measurement can predict the severity of PPH. Their results
also indicated that women more prone for severe bleeding had a
lower body weight than women with non-severe bleeding [1].
Fries et al. showed that in pigs, substitution of ﬁbrinogen together
with packed cells can enhance coagulation and ﬁnal cloth strength,
thereby reducing blood loss and the severity of PPH and ﬁnally reducing
morbidity [2].
As suggested by Ickx (2010): ‘Serious bleeding in women with
uterine atony, abruption of the placenta, and placenta praevia is often
associatedwith excessive ﬁbrinolysis and ﬁbrinogenolysis, often results
in very low levels of plasmaﬁbrinogen and high levels of ﬁbrin D-dimer.
Fibrinogen substitution may therefore play an important role as a ther-
apy in this subgroup. However, the efﬁcacy of the administration of ﬁ-
brinogen concentrates has thus far not been studied in the obstetric
setting' [3].
7. Fibrinogen
Fibrinogen (factor I) is a soluble plasma glycoprotein, that is convert-
ed by thrombin into ﬁbrin during blood clot formation. It is synthesized
in the liver by the hepatocytes. The concentration of ﬁbrinogen in
healthy, non-pregnant adults is between 2.0 and 4.0 g/L. In massive
blood loss, ﬁbrinogen levels may drop below 2.0 g/L, rapidly making
the blood clot formation more difﬁcult and contributing to more severe
bleeding.Studies have shown that the aggressive and early replacement of ﬁ-
brinogen can improve clot strength and survival. A pasteurized ﬁbrino-
gen concentrate has recently been developed. Use of the ﬁbrinogen
concentrate in bleeding patients resulted in signiﬁcant reductions in
red blood cell, fresh frozen plasma and platelet requirements along
with a signiﬁcant reduction in blood loss [4].
8. Discussion
We presumed that ﬁbrinogen levels played a role in our patient's
excessive blood loss at ﬁrst delivery. Because of her clinical history
and the decreasing ﬁbrinogen levels in this pregnancy, a detailed plan
for delivery was made in collaboration with gynaecologists, interven-
tional radiologists, anaesthesiologists and operating staff.
9. Key Message
Major postpartum haemorrhage can be reduced by active manage-
ment during third stage. Collaboration with anaesthesiologists in an
early stage, as in our case presented and administration of ﬁbrinogen
supplementation in case of low maternal serum levels, can be of signif-
icant importance for favourable obstetric outcome. Fibrinogen levels
may play an important role in the majority of the postpartum haemor-
rhage. Perhaps we could prevent major haemorrhage during future
deliveries by ﬁbrinogen.
Further research should give more insight in this matter: Leiden
University Medical Centre has recently set up a multi-centre prospec-
tive cohort study (TeMpOH 2) to identify coagulation parameters
predictive of progressing from mild postpartum haemorrhage into
major obstetric haemorrhage.
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